Recurrent radiation necrosis in the brain following stereotactic radiosurgery

Pract Radiat Oncol. 2015 May-Jun;5(3):e151-e154. doi: 10.1016/j.prro.2014.10.006.

Authors

Gregory M Parker¹, Ian F Dunn², Shakti H Ramkissoon³, Jonathan D Eneman⁴, Michael S Rabin⁵, Nils D Arvold⁶

Affiliations

¹ Harvard Medical School, Boston, Massachusetts.
² Department of Neurosurgery, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts.
³ Department of Pathology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts.
⁴ York Hospital Oncology, York, Maine.
⁵ Department of Medical Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts.
⁶ Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts. Electronic address: narvold@partners.org.

PMID: 25432541
DOI: 10.1016/j.prro.2014.10.006

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Brain / pathology
Brain Edema / etiology
Brain Neoplasms / secondary*
Brain Neoplasms / surgery*
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / pathology*
Craniotomy / methods
Erlotinib Hydrochloride / administration & dosage
Erlotinib Hydrochloride / therapeutic use
Female
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / pathology*
Necrosis / etiology*
Radiation Injuries / pathology
Radiosurgery / adverse effects*

Substances

Erlotinib Hydrochloride